Hsa_circ_0000479/Hsa-miR-149-5p/RIG-I, IL-6 Axis: A Potential Novel Pathway to Regulate Immune Response against COVID-19

Background. COVID-19, the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a global pandemic and mortality of people around the world. Some circular RNAs (circRNAs), one of the new types of noncoding RNAs (ncRNAs), act as competing endogenous RNAs (ceRNAs) a...

Full description

Saved in:
Bibliographic Details
Main Authors: Zahra Firoozi, Elham Mohammadisoleimani, Abbas Shahi, Mohammad Mehdi Naghizadeh, Ebrahim Mirzaei, Ali Ghanbari Asad, Zahra Salmanpour, Seyed Mohamad Javad Nouri, Yaser Mansoori
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:http://dx.doi.org/10.1155/2022/2762582
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561778968494080
author Zahra Firoozi
Elham Mohammadisoleimani
Abbas Shahi
Mohammad Mehdi Naghizadeh
Ebrahim Mirzaei
Ali Ghanbari Asad
Zahra Salmanpour
Seyed Mohamad Javad Nouri
Yaser Mansoori
author_facet Zahra Firoozi
Elham Mohammadisoleimani
Abbas Shahi
Mohammad Mehdi Naghizadeh
Ebrahim Mirzaei
Ali Ghanbari Asad
Zahra Salmanpour
Seyed Mohamad Javad Nouri
Yaser Mansoori
author_sort Zahra Firoozi
collection DOAJ
description Background. COVID-19, the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a global pandemic and mortality of people around the world. Some circular RNAs (circRNAs), one of the new types of noncoding RNAs (ncRNAs), act as competing endogenous RNAs (ceRNAs) and compete with mRNAs for shared miRNAs, to regulate gene expression. In the present study, we aimed to evaluate the expression and roles of hsa_circ_0000479/hsa-miR-149-5p/RIG-I, IL-6 in COVID-19 infection. Materials and Methods. After extraction of total RNA from peripheral blood mononuclear cells (PBMC) of 50 patients with symptomatic COVID-19, 50 patients with nonsymptomatic COVID-19, and 50 normal controls, cDNA synthesis was performed. Online in silico tools were applied to evaluate the interaction between the genes in the hsa_circ_0000479/hsa-miR-149-5p/RIG-I, IL-6 axis, and its role in COVID-19-related pathways. Quantification of the expression of these genes and confirmation of their interaction was done using the quantitative real-time PCR (qRT-PCR) technique. Results. The expression levels of hsa_circ_0000479, RIG-I, and IL-6 were increased in COVID-19 patients compared to healthy controls, while hsa-miR-149-5p expression was decreased. Moreover, there was a significant negative correlation between hsa-miR-149-5p and hsa_circ_0000479, RIG-I, IL-6 expressions, and also a positive expression correlation between hsa_circ_0000479 and IL-6, RIG-I. Then, bioinformatics tools revealed the role of hsa_circ_0000479/hsa-miR-149-5p/RIG-I, IL-6 axis in PI3K-AKT and STAT3 signaling pathways. Conclusion. Upregulation of hsa_circ_0000479, RIG-I, and IL-6, and downregulation of hsa-miR-149-5p, along with correlation studies, indicate that hsa_circ_0000479/hsa-miR-149-5p/RIG-I, IL-6 axis could play a role in regulating the immune response against SARS-CoV-2. However, more studies are needed in this area.
format Article
id doaj-art-865be728a8214cf697b861fe42b93457
institution Kabale University
issn 1918-1493
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Canadian Journal of Infectious Diseases and Medical Microbiology
spelling doaj-art-865be728a8214cf697b861fe42b934572025-02-03T01:24:10ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1918-14932022-01-01202210.1155/2022/2762582Hsa_circ_0000479/Hsa-miR-149-5p/RIG-I, IL-6 Axis: A Potential Novel Pathway to Regulate Immune Response against COVID-19Zahra Firoozi0Elham Mohammadisoleimani1Abbas Shahi2Mohammad Mehdi Naghizadeh3Ebrahim Mirzaei4Ali Ghanbari Asad5Zahra Salmanpour6Seyed Mohamad Javad Nouri7Yaser Mansoori8Department of Medical GeneticsDepartment of Medical BiotechnologyDepartment of ImmunologyNoncommunicable Diseases Research CenterDepartment of Medical GeneticsDepartment of Medical BiotechnologyDepartment of Internal MedicineDepartment of Internal MedicineDepartment of Medical GeneticsBackground. COVID-19, the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a global pandemic and mortality of people around the world. Some circular RNAs (circRNAs), one of the new types of noncoding RNAs (ncRNAs), act as competing endogenous RNAs (ceRNAs) and compete with mRNAs for shared miRNAs, to regulate gene expression. In the present study, we aimed to evaluate the expression and roles of hsa_circ_0000479/hsa-miR-149-5p/RIG-I, IL-6 in COVID-19 infection. Materials and Methods. After extraction of total RNA from peripheral blood mononuclear cells (PBMC) of 50 patients with symptomatic COVID-19, 50 patients with nonsymptomatic COVID-19, and 50 normal controls, cDNA synthesis was performed. Online in silico tools were applied to evaluate the interaction between the genes in the hsa_circ_0000479/hsa-miR-149-5p/RIG-I, IL-6 axis, and its role in COVID-19-related pathways. Quantification of the expression of these genes and confirmation of their interaction was done using the quantitative real-time PCR (qRT-PCR) technique. Results. The expression levels of hsa_circ_0000479, RIG-I, and IL-6 were increased in COVID-19 patients compared to healthy controls, while hsa-miR-149-5p expression was decreased. Moreover, there was a significant negative correlation between hsa-miR-149-5p and hsa_circ_0000479, RIG-I, IL-6 expressions, and also a positive expression correlation between hsa_circ_0000479 and IL-6, RIG-I. Then, bioinformatics tools revealed the role of hsa_circ_0000479/hsa-miR-149-5p/RIG-I, IL-6 axis in PI3K-AKT and STAT3 signaling pathways. Conclusion. Upregulation of hsa_circ_0000479, RIG-I, and IL-6, and downregulation of hsa-miR-149-5p, along with correlation studies, indicate that hsa_circ_0000479/hsa-miR-149-5p/RIG-I, IL-6 axis could play a role in regulating the immune response against SARS-CoV-2. However, more studies are needed in this area.http://dx.doi.org/10.1155/2022/2762582
spellingShingle Zahra Firoozi
Elham Mohammadisoleimani
Abbas Shahi
Mohammad Mehdi Naghizadeh
Ebrahim Mirzaei
Ali Ghanbari Asad
Zahra Salmanpour
Seyed Mohamad Javad Nouri
Yaser Mansoori
Hsa_circ_0000479/Hsa-miR-149-5p/RIG-I, IL-6 Axis: A Potential Novel Pathway to Regulate Immune Response against COVID-19
Canadian Journal of Infectious Diseases and Medical Microbiology
title Hsa_circ_0000479/Hsa-miR-149-5p/RIG-I, IL-6 Axis: A Potential Novel Pathway to Regulate Immune Response against COVID-19
title_full Hsa_circ_0000479/Hsa-miR-149-5p/RIG-I, IL-6 Axis: A Potential Novel Pathway to Regulate Immune Response against COVID-19
title_fullStr Hsa_circ_0000479/Hsa-miR-149-5p/RIG-I, IL-6 Axis: A Potential Novel Pathway to Regulate Immune Response against COVID-19
title_full_unstemmed Hsa_circ_0000479/Hsa-miR-149-5p/RIG-I, IL-6 Axis: A Potential Novel Pathway to Regulate Immune Response against COVID-19
title_short Hsa_circ_0000479/Hsa-miR-149-5p/RIG-I, IL-6 Axis: A Potential Novel Pathway to Regulate Immune Response against COVID-19
title_sort hsa circ 0000479 hsa mir 149 5p rig i il 6 axis a potential novel pathway to regulate immune response against covid 19
url http://dx.doi.org/10.1155/2022/2762582
work_keys_str_mv AT zahrafiroozi hsacirc0000479hsamir1495prigiil6axisapotentialnovelpathwaytoregulateimmuneresponseagainstcovid19
AT elhammohammadisoleimani hsacirc0000479hsamir1495prigiil6axisapotentialnovelpathwaytoregulateimmuneresponseagainstcovid19
AT abbasshahi hsacirc0000479hsamir1495prigiil6axisapotentialnovelpathwaytoregulateimmuneresponseagainstcovid19
AT mohammadmehdinaghizadeh hsacirc0000479hsamir1495prigiil6axisapotentialnovelpathwaytoregulateimmuneresponseagainstcovid19
AT ebrahimmirzaei hsacirc0000479hsamir1495prigiil6axisapotentialnovelpathwaytoregulateimmuneresponseagainstcovid19
AT alighanbariasad hsacirc0000479hsamir1495prigiil6axisapotentialnovelpathwaytoregulateimmuneresponseagainstcovid19
AT zahrasalmanpour hsacirc0000479hsamir1495prigiil6axisapotentialnovelpathwaytoregulateimmuneresponseagainstcovid19
AT seyedmohamadjavadnouri hsacirc0000479hsamir1495prigiil6axisapotentialnovelpathwaytoregulateimmuneresponseagainstcovid19
AT yasermansoori hsacirc0000479hsamir1495prigiil6axisapotentialnovelpathwaytoregulateimmuneresponseagainstcovid19